OIG audits continue to intensify across Medicare and Medicaid, with a growing focus on diagnosis validity, improper payments, and concerns related to fraud, waste, and abuse—particularly in areas such as skin substitutes and podiatry. High‑risk diagnoses that lack clear face‑to‑face documentation or appear to influence risk‑adjusted payments are increasingly targeted.

This session outlines what organizations need to know as OIG scrutiny expands. Attendees will learn how auditors assess diagnosis legitimacy, documentation sufficiency, and linkage to valid provider encounters. We will also review the broad and in‑depth nature of OIG audits, including their potential outcomes—from significant repayment demands to corrective action plans and referrals for further investigation.

Participants will leave with practical insight into preparing teams, strengthening documentation practices, and reducing exposure to escalating compliance risk.